Descriptor English: | Stanozolol | ||||||
Descriptor Spanish: |
Estanozolol
| ||||||
Descriptor Portuguese: | Estanozolol | ||||||
Descriptor French: | Stanozolol | ||||||
Entry term(s): |
Androstanazol Methylstanazol Stanazolol Stromba Winstrol |
||||||
Tree number(s): |
D04.210.500.054.040.881 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D013197 | ||||||
Scope note: | A synthetic steroid that has anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1194) |
||||||
Annotation: | an anabolic steroid |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Androgens Anabolic Agents |
||||||
Registry Number: | 4R1VB9P8V3 | ||||||
CAS Type 1 Name: | 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)- | ||||||
Public MeSH Note: | 65 |
||||||
History Note: | 65(64) |
||||||
DeCS ID: | 13584 | ||||||
Unique ID: | D013197 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1965/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Stanozolol
- Preferred
Stromba
- Narrower
Concept UI |
M0020415 |
Scope note | A synthetic steroid that has anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1194) |
Preferred term | Stanozolol |
Entry term(s) |
Androstanazol Methylstanazol Stanazolol |
Concept UI |
M0020416 |
Preferred term | Stromba |
Entry term(s) |
Winstrol |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey